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Abstract
Chronic exposure to inorganic arsenic (iAs) has been linked to diabetic phenotypes in both humans and mice. However, dia-
betogenic effects of iAs exposure during specific developmental windows have never been systematically studied. We have 
previously shown that in mice, combined preconception and in utero exposures to iAs resulted in impaired glucose homeo-
stasis in male offspring. The goal of the present study was to determine if preconception exposure alone can contribute to 
this outcome. We have examined metabolic phenotypes in male and female offspring from dams and sires that were exposed 
to iAs in drinking water (0 or 200 μg As/L) for 10 weeks prior to mating. The effects of iAs exposure on gene expression 
profiles in parental germ cells, and pancreatic islets and livers from offspring were assessed using RNA sequencing. We 
found that iAs exposure significantly altered transcript levels of genes, including diabetes-related genes, in the sperm of sires. 
Notably, some of the same gene transcripts and the associated pathways were also altered in the liver of the offspring. The 
exposure had a more subtle effect on gene expression in maternal oocytes and in pancreatic islets of the offspring. In female 
offspring, the preconception exposure was associated with increased adiposity, but lower blood glucose after fasting and after 
glucose challenge. HOMA-IR, the indicator of insulin resistance, was also lower. In contrast, the preconception exposure 
had no effects on blood glucose measures in male offspring. However, males from parents exposed to iAs had higher plasma 
insulin after glucose challenge and higher insulinogenic index than control offspring, indicating a greater requirement for 
insulin to maintain glucose homeostasis. Our results suggest that preconception exposure may contribute to the development 
of diabetic phenotype in male offspring, possibly mediated through germ cell-associated inheritance. Future research can 
investigate role of epigenetics in this phenomenon. The paradoxical outcomes in female offspring, suggesting a protective 
effect of the preconception exposure, warrant further investigation.
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Introduction
Type 2 diabetes is a prevalent medical condition that poses 
a significant public health concern. According to the 2020 
National Diabetes Statistics Report, nearly 34.2 million in 
the United States are affected by this chronic disease (CDC 
2020). Exposure to chemicals and other environmental fac-
tors has been shown to contribute to the increasing preva-
lence of diabetes (Ardisson Korat et al. 2014; Thayer et al. 
2012). The etiology of type 2 diabetes is complex and can 
elicit multiple factors, including genetics and environment 
interactions (Romao and Roth 2008).
Inorganic arsenic (iAs) is a ubiquitous environmental 
metalloid that is present in drinking water, soil, food, 
and other consumer products (Chung et al. 2014). In 
drinking water, levels of iAs are shown to exceed the 
WHO limit of 10 μg As/L in many regions of the United 
States, Bangla-desh, India, China, and Taiwan, and parts 
of South Amer-ica (Naujokas et al. 2013; WHO 2017). 
Chronic exposure to iAs is associated with cancer and 
other adverse health outcomes (Abdul et al. 2015; 
Kapaj et al. 2006; Maull et al. 2012). Diabetogenic 
effects of iAs exposures have been well studied in both 
humans and rodents (Maull et al. 2012). In humans, 
many epidemiological studies world-wide have linked 
iAs exposures with diabetes (Lai et al. 1994; Navas-
Acien et al. 2008; Rahman et al. 1998; Tseng et al. 2000). 
In mice, iAs is shown to impair glucose home-ostasis 
with or without dietary modifications (Castriota et al. 
2020; Liu et al. 2014; Paul et al. 2007, 2011). Several 
molecular mechanisms for iAs-induced glucose dysregu-
lation have been reported. These include oxidative 
stress, epigenetic alterations, and inflammatory 
signaling (Beck et al. 2017; Carmean and Seino 2019; 
Martin et al. 2017; Tseng 2004). IAs exposure is also 
associated with insulin resistance and β-cell dysfunction 
in both humans and mice (Douillet et al. 2013; Grau-
Perez et al. 2017; Liu et al. 2014; Padmaja Divya et al. 
2015). A postulated underly-ing mechanism for arsenic-
dependent insulin resistance is the down-regulation of 
the insulin-stimulated protein kinase B (Akt) signaling 
pathway (Paul et al. 2011; Walton et al. 2004; Zhang 
et al. 2017), while impaired mitochon-drial metabolism 
and inhibition of calcium influx appear to underlie the 
inhibition of insulin secretion by β-cells (Dover et al. 
2018a, b; Huang et al. 2019). In humans, exposure to 
iAs often occurs over a lifetime; however, 
diabetogenic effects of iAs exposure at specific 
develop-mental windows, including exposure of parental 
germ cells prior to conception, has never been 
systematically exam-ined. Some data in humans (Kile 
et al. 2014; Rager et al. 2014; Rojas et al. 2015) and 
mice (Fry et al. 2019; Huang et al. 2018) suggest that 
prenatal exposures play a role in diabetes development 
in offspring. But the specific role of 
preconception exposure alone on phenotypic outcomes in 
the offspring remains unclear.
The present study focuses on characterizing gene expres-
sion changes in germline cells from parental mice exposed 
to iAs as a potential mechanism by which preconception 
exposure to iAs may alter metabolic phenotypes in offspring. 
We hypothesized that preconception exposure to iAs would 
lead to changes in transcript levels in parental germline cells 
and in an adverse metabolic phenotype in offspring. We fur-
ther hypothesized that offspring target tissue transcription 
profiles would reflect the preconception-associated germline 
transcription. To address this hypothesis, we conducted met-
abolic phenotyping and tissue-specific RNA sequencing in 
male and female offspring from parents that were exposed to 
iAs prior to conception. Our study highlights novel findings 
that suggest the preconception iAs exposure plays a role in 
glucose dysregulation in adult mice in a sex-specific manner.
Materials and methods
Preconception exposure to iAs
All procedures involving mice were approved by the 
UNC Institutional Animal Care and Use Committee. 
Twenty male and 40 female C57BL/6J mice (6 weeks old) 
were purchased from the Jackson Laboratory (Bar Har-
bor, ME) and housed in the UNC animal facilities. All 
mice were singly caged upon arrival. The housing room 
was set on a 12-h light–dark cycle. The experimental 
design of the study is shown in Fig. 1. All mice were left 
to acclimatize for 2 weeks while fed AIN-93G food pel-
lets (Research Diets Inc., New Brunswick, NJ) and drank 
arsenic-free deionized water (DIW). After acclimatiza-
tion, all mice were arbitrarily separated into two exposure 
groups. Twenty female and 10 male mice were exposed to 
sodium arsenite in deionized water (200 µg As/L, ppb) for 
10 weeks. The remaining animals in the second, control 
group continued drinking DIW. Sodium arsenite (> 99% 
pure) was purchased from Sigma Aldrich (St. Louis, MO). 
Drinking water in both groups was changed weekly. Water 
consumption was recorded on a weekly basis; food con-
sumption was monitored every 2 weeks. The body weights 
were monitored biweekly. On week 9 of exposure, mice 
were fasted for 6 h, and tail bleeds were performed to 
measure fasting blood glucose (FBG) and fasting plasma 
insulin (FPI). After week 10, iAs exposure was terminated, 
and ten male and ten female mice from each treatment 
group were mated (one on one) for 1 week. During this 
time, all mice drank DIW. The ten remaining female mice 
in each treatment group were sacrificed, and oocytes were 
collected from ovaries. Following the mating period, the 
males were also sacrificed, and sperm was collected from 
cauda epididymis. (The methods used for oocyte and 
sperm isolation are described below.) The mated females 
were singly housed and closely monitored for pregnancy 
and pup births.
Offspring
At weaning (i.e., at 22 days of age), the G1 mice (the 
offspring) were weighed and singly housed. All G1 mice 
drank DIW ad libitum and were fed the AIN-93G diet. The 
body weights, food, and water consumption were moni-
tored as described for the parental generation. Magnetic 
resonance imaging (MRI) using Echo MRI three-in-one 
Composition Analyzer and Labmaster (Echo Medical 
Systems, Houston, TX, USA) was conducted at 11 and 
23 weeks of age to determine body composition (%fat and 
%lean mass). Metabolic phenotypes were also assessed 
at 11 and 23 weeks of age. Specifically, FBG and FPI 
were measured after 6-h fasting. Fasted mice were then 
injected intraperitoneally with d-glucose (Sigma Aldrich, 
St. Louis, MO) in phosphate-buffered saline (2 g glucose/
kg b.w.) and blood glucose and plasma insulin were meas-
ured 15 min post-dosing. After completion of the pheno-
type analysis at 23 weeks of age, mice were euthanized 
by cervical dislocation. Pancreatic islets were isolated 
as described below. The islets, along with other tissues 
collected after sacrifice, were flash frozen and stored at 
− 80 °C.
Analysis of blood glucose and plasma insulin
For both parental generation and the offspring, blood (~ 100 
μL) was collected from tail cuts in ammonium heparin-
coated capillary tubes from Kimble (Dover, Ohio). Glucose 
levels were measured in whole blood by One  Touch®  Ultra® 
glucometer (LifeScan, Inc., Milpitas, CA). Plasma was iso-
lated by centrifugation at 1700×g for 15 min at 4 °C and 
stored at − 80 °C. Plasma insulin levels were measured using 
ELISA kits from Crystal Chem (Elk Grove Village, IL) fol-
lowing the manufacturer’s protocol.
Calculation of metabolic indices
Homeostasis assessment-insulin resistance (HOMA-IR) 
index, an indicator of insulin resistance, was calculated 
using FBG (mg/dL) and FPI (μU/mL) as follows: HOMA-
IR = [(FBG) × (FPI)]/405. FBG was expressed in mmol/mL 
for calculation of HOMA-β cell function (HOMA-B) index 
using the equation HOMA-B = [FPI × 20]/[FBG − 3.5]. 
The insulinogenic index, an indicator of β cell function in 
response to glucose challenge, was calculated as  (FPI15min 
− FPI Basal)/(FBG15min −  FBGBasal).
Oocyte collection
The oocytes were collected by manual extraction meth-
ods from the ten control and ten iAs-exposed females 
that were not involved in mating. The media required to 
Fig. 1  Experimental design. After acclimatization for 2  weeks, 20 
male and 2 × 20 female mice were exposed to 0 or 200 ppb iAs in 
drinking water for 10 weeks. Phenotyping was performed at week 9. 
At week 10, oocytes were isolated from ten females after sacrifice. 
The remaining ten females and ten males were mated (one on one) 
for 1 week. After mating, sperm was collected from males. Offspring 
born to pregnant dams were weaned at age of 3 weeks. Phenotype of 
the offspring was examined at age of 11 and 23 weeks. Tissues were 
collected from 23-week-old offspring after sacrifice
collect oocytes was freshly prepared before organ har-
vests. Minimum essential medium (MEM) Eagle’s media, 
sodium bicarbonate, polyvinylpyrrolidone (PVP), sodium 
pyruvate, 1 M HEPES buffer, gentamycin (50 mg/mL), 
and Milrinone, a blood vessel vasodilator, were purchased 
from either Sigma Aldrich (St. Louis, MO) or Fischer Sci-
entific (Hampton, NH). In brief, 90 mL of MEM media 
was taken in a beaker, and 0.22 g of sodium bicarbonate 
was added to it. 0.3 g of PVP and 0.01 g of sodium pyru-
vate were added to the above solution. 2.5 mL of 1 M 
HEPES and 0.1 mL of gentamycin (50 mg/mL) were ali-
quoted to the above solution. The pH was adjusted to 7.3, 
and the prepared media was made up to 100 mL and trans-
ferred to a bottle wrapped in foil and placed in a water bath 
maintained at 37 °C. 2.5 mM of milrinone was added to 
the media to prevent oocyte maturation. Media contain-
ing milrinone was transferred to a 60 × 15-mm Petri dish. 
Ovaries were isolated during necropsy and separated from 
surrounding adipose tissues. The clean ovaries were then 
placed in the Petri dish with media. Using  255/8 G syringe 
needles, ovaries were shredded under a Nikon SMZ 
800 N microscope (Minato, Tokyo). A mouth pipette was 
assembled with a silicon tip from Drummond Scientific 
Company (Broomall, PA). The other end of the silicon tip 
was attached to a stripper or capillary plastic tube with 
an internal diameter of 75 µm from Cooper Surgical Inc. 
(Trumbull, CT). The mouth pipette setup was used to strip 
cumulous cells and other debris from oocytes by pipetting 
back and forth. The oocytes were then transferred into an 
Eppendorf tube containing RNase inhibitor (Qiagen, MD) 
and placed on dry ice.
Sperm collection
Sperm was collected using the swim out method from ten 
sires immediately after 1 week of mating. The buffer for 
sperm collection was freshly prepared before necropsy. 
Human Tubal Fluid (HTF) HEPES buffer was purchased 
from Fisher Scientific (Hampton, NH). Bovine serum 
albumin (BSA) was purchased from Sigma Aldrich (St. 
Louis, MO). BSA was added to the buffer so that the final 
concentration was 5 mg/mL. The vas deferens and cauda 
epididymis were transferred into 1 mL of warm 1X HTF 
on a well plate. Using a  26½ G syringe needle, the vas 
deferens and epididymis were thoroughly scored to release 
sperm cells into the media. The media was incubated for 
10 min at 37 °C incubator to allow sperm to swim out to 
the media. The media was then transferred to a 1.5-mL 
Eppendorf tube and centrifuged at 12,000g for 5 min. The 
supernatant was removed, and the pellet containing the 
sperm cells was frozen in dry ice.
Isolation of pancreatic islets
Islets were isolated from pancreata of male and female off-
spring using the previously described in situ collagenase 
perfusion method followed by centrifugation in Ficoll PM 
400 (GE Healthcare, Uppsala, Sweden) (Douillet et al., 
2013). Collagenase P was purchased from Roche Diagnos-
tics Corp. (Indianapolis, IN). The islets were washed with 
Hank’s balanced Salt Solution containing 10 mM HEPES, 
7.5% sodium bicarbonate and 0.25% BSA (all from Sigma 
Aldrich); pH was adjusted to 7.4.
RNA sequencing and differential gene expression 
analysis in sperm and oocytes from parental mice
Sperm and oocyte samples, five per treatment group, were 
selected from the parental generation for RNA sequencing. 
Total RNA extraction, library preparation, sequencing, and 
reads alignment was conducted at the UNC Center for Gas-
trointestinal Biology and Disease (CGIBD) Advanced Ana-
lytical Core. SMART-seq v4 Ultra Low RNA kit was pur-
chased from TaKaRa Bio USA, Inc. (Mountain View, CA) 
for RNA extraction. cDNA libraries were prepared using 
Nextera XT DNA Library Preparation Kit from  Illumina® 
(San Diego, CA). Sequencing was conducted using NextSeq 
500/500 v2.5 (150 cycles) kits from  Illumina® (San Diego, 
CA). Reads were aligned to the mm9 genome using Spliced 
Transcripts Alignment to a Reference (STAR) (Dobin et al. 
2013). Differential gene expression was assessed using the 
DESeq package (Love et al. 2014). Transcriptome data were 
filtered to genes with absolute read counts of more than 10 
in all sperm and oocyte samples for differential gene expres-
sion analysis (Venkatratnam et al. 2018). Differentially 
expressed genes were identified based on Benjamini–Hoch-
berg FDR < 0.1. Pathway analysis was conducted using the 
Database for Annotation, Visualization and Integrated Dis-
covery (DAVID) (Dennis et al. 2003; Huang et al. 2009). 
The differentially expressed genes with p values < 0.05 were 
used for pathway analyses.
RNA sequencing and differential gene expression 
analysis in pancreatic islets and livers from offspring
RNA sequencing was carried out in islets from three male 
and five female offspring from the control parents and five 
male and five female offspring from iAs-treated parents. 
RNA sequencing was also carried out in livers from five 
male and six female offspring from control parents and five 
male and five female offspring from iAs-treated parents. 
RNA was extracted from islets using RNAqueous micro 
kit from  Ambion® (Austin, TX). cDNA libraries were pre-
pared using SEQuoia Complete Stranded RNA Library 
Kit from Bio-Rad laboratories (Hercules, CA). RNA from 
livers was extracted using RNeasy mini kit from Qiagen 
(Germantown, MD). cDNA libraries were prepared using 
Next Ultra II Directional RNA Library Prep Kit from New 
England Biolabs Inc (Ipswich, MA). Islet and liver RNA was 
sequenced using NextSeq 500/500 v2.5 (77 cycles) kits from 
 Illumina® (San Diego, CA). Reads alignment, differential 
gene expression, and pathway analysis were conducted as 
described above.
Data analysis of phenotypic endpoints
GraphPad Prism (La Jolla, CA) and R studio (Boston, CA) 
were used for data analysis and visualizations. Data from 
metabolic phenotyping were screened for outliers using 
Grubb’s outlier test. These data are presented in scatterplots 
graphs where the bars represent the mean and standard devi-
ation. The data represent observations in male (N = 10, 25) 
and female (N = 10, 28) control and iAs nests. Mann–Whit-
ney non-parametric test was used to characterize differences 
between treatment groups and sexes; p < 0.05 was used as a 
threshold for statistical significance.
Results
Phenotypic characteristics of the parental mice
No statistically significant difference in FBG and FPI were 
observed between control and iAs-exposed males or females 
from the parental generation (Suppl. Figure 1A, B, C, D). 
Similarly, no treatment-related differences were found in 
HOMA-IR and HOMA-B (Suppl. Figure 1E, F, G, H).
Transcriptomic responses in sperm cells and oocytes 
of parental mice exposed to iAs
Gene expression profiles were examined in the oocytes 
that were collected from the control and iAs-exposed vir-
gin females and in the sperm collected from control and 
iAs-exposed sires after mating. RNA sequencing identified 
912 and 180 genes differentially expressed in response to iAs 
exposure (p < 0.05) in sperm cells and oocytes, respectively 
(Suppl. Tables 1 and 2). After false discovery rate correc-
tion using Benjamini–Hochberg method, five genes were 
identified to show altered expression due to iAs exposure in 
sperm cells, namely protein tyrosine phosphatase non-recep-
tor type 22 (Ptpn22), cluster of differentiation 240 (Cd240), 
chemokine (C–C motif) ligand 8 (Ccl8), major vault pro-
tein (Mvp), and ras-related protein (Rab3d) were statistically 
significant (FDR < 0.1) (Table 1). Interestingly, no statisti-
cally significant effects of iAs exposure on gene expression 
in oocytes were found at FDR < 0.1. Pathway enrichment 
analysis was conducted using DAVID via the KEGG and 
BioCarta pathways. The genes (n = 912; p < 0.05) altered 
by iAs exposure in sperm cells have known roles in several 
biological pathways including Focal adhesion, Insulin-like 
growth factor binding, Phosphoinositide 3 kinase/protein 
kinase B (PI3K-Akt) signaling, extracellular matrix receptor 
interaction, and Wingless-related integration site (Wnt) sign-
aling that were significantly perturbed (FDR < 0.1) and are 
relevant to glucose dysregulation (Table 2). No statistically 
significant pathway perturbation was observed in oocytes.
Numbers and sex of the offspring
Nine out of ten dams exposed to iAs prior to mating gave 
birth to offspring. In contrast, the mating of ten control pairs 
resulted only in three litters (Suppl. Table 3). Thus, the G1 
generation consisted of 10 females and 10 males from the 
control parents and 29 females and 27 males from iAs-
treated parents. Two males and one female from iAs-treated 
parents died later after weaning for unknown causes.
Table 1  Genes that were 
differentially expressed in 
sperm cells of sires exposed 
to iAs
Sperm was collected after mating from males exposed to iAs for 10 weeks prior to mating and unexposed 
control males. Differentially expressed genes were identified based on Benjamini–Hochberg adjusted p 
value < 0.1
Gene Base mean Log2 fold change p value Benjamini–Hoch-
berg adjusted p 
value
Protein tyrosine phosphatase, non-
receptor type 22 (Ptpn22)
133.95 − 0.90 6.38E−06 0.05
Cluster of differentiation (CD248) 84.67 1.28 1.12E−05 0.05
Chemokine (C–C motif) ligand 8 (Ccl8) 297.20 1.04 1.84E−05 0.05
Major vault protein (Mvp) 231.27 0.48 2.13E−05 0.05
Ras-related protein Rab-3D (Rab3d) 145.55 0.58 4.35E−05 0.08
Phenotypic characteristics of the G1 offspring
Food and water consumption, and body weights
Body weights of the offspring were monitored weekly from 
weaning (i.e., week 3 of age) until week 23 of age. During 
this period, male and female mice in both treatment groups 
steadily gained weight (Suppl. Figure 2A). Male mice were 
heavier compared to females by the end of the study. There 
were no statistically significant differences between males 
or females due to treatment. Food and water consumption 
were relatively steady for most duration of the study. Food 
consumption varied between 2.5 and 3.5 g/day and tended 
to be higher in males as compared to females (Suppl. Fig-
ure 2B). Water consumption ranged from 2.5 to 6.2 g/day 
(Suppl. Figure 2C).
Body composition
At 11 weeks of age, no significant differences were detected 
in body composition (% fat and % lean mass) between the 
treatment groups or between males and females within each 
treatment group (Suppl. Figure 3). At 23 weeks of age, no 
treatment-related differences were found in body composi-
tion of G1 males (Fig. 2a, c); however, females from the iAs-
exposed parents had significantly higher % fat than females 
from the control parents (p = 0.01) (Fig. 2b). There were 
no significant treatment-related differences in % lean mass 
among G1 females (Fig. 2d). At 23 weeks of age, G1 males 
had significantly higher % fat than females in the treatment 
group (p = 0.0003), but not in the control group (p = 0.052) 
(Fig. 2a, b). At this age, % lean mass in G1 females were 
significantly (p = 0.0092) higher than in males within the 
iAs-exposed parental group (Fig. 2c, d).
Blood glucose and plasma insulin
FBG and FPI, as well as blood glucose and plasma insu-
lin levels 15 min after glucose challenge were measured 
at 11 and 23 weeks of age. At week 11, there were only 
few significant differences in the glucose and insulin meas-
ures between treatment groups or between sexes (Suppl. 
Figure 4). Specifically, FBG was lower in females from 
iAs-treated parents than in females from control parents 
(p = 0.039); Δ  glucose(15–0min) value (i.e., the difference 
between 15-min glucose and FBG) was greater in males 
from iAs-exposed parents as compared to males from con-
trol parents (p = 0.028). The same differences were found in 
the offspring at 23 weeks of age, but at this time point, these 
differences were not statistically significant: p = 0.07 for the 
difference in FBG in females and p = 0.09 for the difference 
in Δ  glucose(15–0min) in males (Suppl. Figure 5). However, 
a statistically significant difference was found in 15-min 
blood glucose among the female offspring; 15-min glucose 
was lower in females from iAs-treated parents (Suppl. Fig-
ure 5D). At 23 weeks, 15-min plasma insulin was higher in 
males from iAs-exposed parents as compared to controls 
(p = 0.02) (Suppl. Figure 6). In contrast, no statistically sig-
nificant treatment-related differences were found among the 
female offspring.
Since we found that % fat differed significantly between 
females from the control and iAs-treated parents and because 
adiposity is known to affect blood glucose and insulin lev-
els, we re-assessed the differences in blood glucose and 
plasma insulin levels at week 23 while normalizing for % 
fat. We found that the normalized FBG, 15-min glucose, 
and Δ  glucose(15–0 min) were significantly lower (p < 0.025) 
in females from the iAs-treated nests as compared to females 
from the control nests (Fig. 3b, d, f). There were no statisti-
cally significant treatment-related differences in the glucose 
measures among males (Fig. 3a, c, e). The normalized FPI 
and 15-min plasma insulin were found to be lower in females 
from the iAs-treated parents than in those from the control 
parents (Fig. 4a, b) with p = 0.074 and p = 0.017, respec-
tively. Differences were also found in the normalized 15-min 
insulin (p = 0.003) and Δ  insulin(15–0min) (p = 0.07) among 
male offspring; both values were higher in males from the 
iAs-treated parents (Fig. 4c, d).
Table 2  Top pathways in sperm 
cells that were significantly 
enriched for genes (n = 912) 
altered by exposure to iAs
Differentially expressed genes (p < 0.05) were analyzed for pathways enrichment; the significantly enriched 
pathways were identified using a Benjamini–Hochberg adjusted p value < 0.1
Category Pathway Fold enrichment p value Benjamini–Hoch-
berg adjusted p 
value
KEGG Focal adhesion 3.25 9.71E−08 2.43E−05
KEGG PI3K-Akt signaling pathway 2.53 3.57E−07 4.46E−05
KEGG ECM-receptor interaction 3.82 6.08E−05 0.005
Gene ontology Collagen trimer 4.05 3.59E−05 0.001
Gene ontology Insulin-like growth factor binding 8.35 2.84E−05 0.006
Gene ontology Positive regulation of non-canoni-
cal Wnt signaling
19.54 4.57E−05 0.024
While focusing on the effects of iAs exposure, we also 
found statistically significant differences between males 
and female offspring within each treatment group. Spe-
cifically, the normalized FBG was significantly higher 
in females compared to males regardless of treatment 
(p = 0.0082). The normalized 15-min glucose and normal-
ized Δ  glucose(15–0min) were significantly higher in females 
than males from the control parents (p = 0.007). The nor-
malized 15-min plasma insulin was significantly higher in 
females than males from the control parents (p = 0.0288), 
but was significantly lower in females than males from 
the iAs-treated parents (p = 0.0007). The normalized Δ 
 insulin(15–0min) was higher in males compared to females 
from the iAs-treated parent, but this difference did not reach 
statistical significance (p = 0.0522).
Insulin resistance and β‑cell function
We used FBG and FPI values to calculate HOMA-IR, an 
indicator of insulin resistance, and HOMA-B, an indicator 
of β-cell function. Insulinogenic index was calculated to 
evaluate β-cell function after glucose challenge. We found 
no statistically significant differences in HOMA-IR or 
HOMA-B values among the treatment groups (Suppl. Fig-
ure 7). However, the insulinogenic index was higher in males 
from iAs-treated parents as compared to controls (p = 0.05); 
no difference was found among females (Suppl. Figure 7E, 
F). When normalized for % fat HOMA-IR was found to be 
significantly lower in females from the iAs-treated parents 
as compared to the control parents (p = 0.04) (Fig. 5b), no 
significant differences were found in the normalized HOMA-
B or insulinogenic index (Fig. 5d, f). In contrast, the precon-
ception exposure had no significant effects on the normal-
ized HOMA-IR and HOMA-B in the male offspring (Fig. 5a, 
c). However, the normalized insulinogenic index for males 
from the iAs-treated parents was significantly higher than 
for males from the control parent (p = 0.0269) (Fig. 5e). Sex-
related differences were found only among offspring from 
iAs-treated parents. The normalized HOMA-IR was sig-
nificantly higher in males compared to females (p = 0.0287) 
and normalized HOMA-B was higher in females than males 
(p = 0.0234). In addition, the normalized insulinogenic index 
was significantly higher in males compared to females 
(p = 0.0473).
Fig. 2  Body composition of 
23-week-old male and female 
offspring from parents exposed
to iAs prior to mating and from 
control, unexposed parents:
percent body weigh represented
by fat (percent fat) in male (a)
and female (b) offspring, and 
percent body weight represented
by lean mass (percent lean
mass) in male (c) and female
(d) offspring. Scatter plots show 
mean, ± SD and individual val-
ues. p values for the statistically 
significant differences (p < 0.05) 
between treatments are shown
Transcriptomic responses in islets and livers of male 
and female offspring from iAs‑treated parents
We compared transcript levels in the islets and livers of 
male and female offspring from iAs-treated parents to those 
in the islets and livers of the control offspring using RNA 
sequencing.
In the islets of female and male offspring, 99 and 100 
genes were differentially expressed in response to the 
preconception iAs exposure (p < 0.05), respectively (Suppl. 
Tables 4 and 5). However, no statistically significant dif-
ferences between the transcript levels in the islets from the 
control and treatment groups were found after adjusting 
for multiple testing using Benjamini–Hochberg method. 
Pathway enrichment analysis of the n = 100 differentially 
expressed genes (p < 0.05) identified multiple pathways 
altered by the preconception exposure to iAs in male islets; 
pathways involved in translational processes were among the 
Fig. 3  Fasting blood glucose (a, 
b), 15-min blood glucose (c, d) 
and delta glucose (i.e., 15-min 
glucose – fasting glucose) (e, f) 
normalized to percent body fat 
in 23-week-old male and female 
offspring from iAs-treated and 
control parents. Scatter plots 
show mean, ± SD and individual 
values. p values for the statisti-
cally significant differences 
(p < 0.05) between treatments 
are shown
most significantly affected (FDR < 0.1) (Suppl. Table 6). No 
pathways were significantly altered in female islets.
In the liver, the transcriptomic responses were con-
siderably stronger than in the islets. The preconcep-
tion exposure altered 1407 and 843 genes significantly 
(p < 0.05) in the livers of the female and male offspring, 
respectively (Suppl. Tables 7 and 8). After adjusting for 
false discovery rates, eight genes in the female livers, and 
one gene in the male livers were found to be significantly 
perturbed (FDR < 0.1) (Table 3). In female livers, these 
genes included AarF domain containing kinase 5 (Adck5), 
Hydroxypyruvate isomerase (Hyi), BTG3-associated 
nuclear protein (Banp), ATP-binding cassette sub-family A 
member 9 (Abca9), Cytochrome B-245 beta chain (Cybb), 
Ubiquitin-like modifier activating enzyme 6 (Uba6), ADP 
ribosylation factor Like GTPase 4D (Arl4d), and Aspara-
ginase (Aspg). Expression of G0/G1 switch gene 2 (G0s2) 
was found to be altered in male livers. Pathway analysis 
using differentially expressed genes with p values < 0.05 
(n = 843) identified several pathways that were altered in 
 
Fig. 4  Fasting plasma insulin 
(a, b), 15-min plasma insulin 
(c, d), and delta insulin (i.e., 
15-min insulin–fasting insulin)
(e, f) normalized to percent
body fat in 23-week-old male
and female offspring from
iAs-treated and control parents. 
Scatter plots show mean, ± SD,
and individual values. p values
for the statistically significant 
differences (p < 0.05) a re shown 
along with p values that are
higher than 0.05 but lower than
0.1
male livers by the preconception iAs exposure, includ-
ing extracellular matrix (ECM) receptor interaction, focal 
adhesion, and PI3K-Akt signaling pathways (Table 4). The 
differentially expressed genes in female livers (n = 1407) 
were enriched in pathways associated, for example, with 
ribosomal structure and function, with mitochondrial res-
piration and oxidative phosphorylation, non-alcoholic fatty 
liver disease, and NADH dehydrogenase activity (Table 5).
Genes differentially expressed in both the parental 
germ cells and the tissues of the offspring
We compared genes that were differentially expressed 
in the parental germline cells with genes differentially 
expressed in the islets and livers of the offspring using the 
p < 0.05 threshold. We identified 95 genes in livers of male 
and 81 genes in livers of female offspring that were also 
Fig. 5  HOMA-IR (a, b), 
HOMA-B (c, d), and insulino-
genic index (e, f) normalized to 
percent body fat in 23-week-old 
male and female offspring from 
iAs-treated and control parents. 
Scatter plots show mean, ± SD, 
and individual values. p values 
for the statistically significant 
differences (p < 0.05) between 
treatments are shown
differentially expressed in paternal sperm (Suppl. Tables 9 
and 10). Similarly, we found 6 genes in male livers and 20 
in female livers that were also differentially expressed in 
maternal oocyte (Suppl. Table 11). There were very few 
overlaps between genes differentially expressed in the germ 
cells and in the islets of the offspring (data not shown). We 
performed pathway analysis using genes that were differ-
entially expressed in both paternal sperm and in livers of 
the male offspring (n = 95) and female offspring (n = 81). 
We identified 16 biological pathways in livers of the male 
offspring that were enriched for these genes (Table 6). As 
discussed below, some of these pathways are involved in 
Table 3  Genes that were differentially expressed (n = 9) in livers of female and male offspring from parents exposed to iAs
Differentially expressed genes were identified based on Benjamini–Hochberg adjusted p value < 0.1
Gene (male livers) Base mean Log2 fold change p value Benjamini–Hochberg adjusted p value
G0/G1 switch gene 2 (G0s2) 2364.91 − 1.820 7.91E−06 0.087
Gene (female livers) Base mean Log2 fold change p value Benjamini–Hochberg adjusted p value
AarF domain containing kinase 5 (Adck5) 550.79 − 0.74029 5.69E−07 0.006271
Hydroxypyruvate isomerase (Hyi) 1062.55 − 0.77357 2.42E−06 0.008925
BTG3-associated nuclear protein (Banp) 209.52 − 1.01104 2.43E−06 0.008925
ATP-binding cassette sub-family A member 9 (Abca9) 80.86 0.732965 1.49E−05 0.040947
Cytochrome B-245 beta chain (Cybb) 465.07 0.619609 1.86E−05 0.041049
Ubiquitin-like modifier activating enzyme 6 (Uba6) 112.97 0.788383 5.34E−05 0.097647
ADP ribosylation factor Like GTPase 4D (Arl4d) 349.28 − 0.71922 7.06E−05 0.097647
Asparaginase (Aspg) 3185.9 − 0.42721 7.09E−05 0.097647
Table 4  Top pathways in livers of male offspring that were significantly enriched for genes (n = 843) altered by preconception exposure to  iAsa
Differentially expressed genes (p < 0.05) were analyzed for pathways enrichment; the significantly enriched pathways were identified using a 
Benjamini–Hochberg adjusted p value < 0.1
Category Pathway Fold enrichment p value Benjamini–Hoch-
berg adjusted p 
value
KEGG Focal adhesion 2.69 9.71E−06 0.001
KEGG ECM-receptor interaction 3.41 1.90E−04 0.006
KEGG PI3K-Akt signaling pathway 1.89 8.38E−04 0.023
Gene ontology Cell cycle 1.98 8.46E−06 0.006
Gene ontology Platelet-derived growth factor binding 12.32 6.73E−05 0.011
Gene ontology Extracellular matrix structural constituent 5.40 2.04E−04 0.017
KEGG Protein digestion and absorption 2.92 0.002381 0.049
Gene ontology Collagen trimer 3.052 0.005332 0.079
Gene ontology Leukocyte cell–cell adhesion 8.29 3.11E−05 0.014
Gene ontology Membrane to membrane docking 19.89 6.07E−04 0.086
Gene ontology ATP binding 1.45 2.92E−04 0.023
Gene ontology Nucleotide binding 1.38 3.37E−04 0.024
Gene ontology Cadherin binding involved in cell–cell adhesion 2.20 4.45E−04 0.027
Gene ontology Cell–cell adherens junction 2.00 0.00175 0.031
Gene ontology MCM complex 14.07 2.58E−04 0.007
Gene ontology DNA unwinding involved in DNA replication 12.43 4.46E−04 0.070
KEGG DNA replication 4.29 0.004963 0.086
Gene ontology Chromosome condensation 9.32 3.11E−04 0.061
Gene ontology Membrane to membrane docking 19.89 6.07E−04 0.086
KEGG Bladder cancer 5.23 8.46E−05 0.005
Gene ontology Phosphatidylinositol-3,4-bisphosphate binding 6.72 0.001597 0.071
Gene ontology GO:0030261 ~ chromosome condensation 9.32 3.11E−04 0.061
the regulation of glucose homeostasis and/or are linked to 
pathologies associated with diabetes. No pathways were 
significantly enriched for the genes that were differentially 
expressed in the sperm and the livers of female offspring.
Discussion
The association between chronic iAs exposure from drinking 
water and type 2 diabetes has been supported by results of 
multiple cross-sectional and prospective population studies 
(Thayer et al. 2012). Almost all these studies have been car-
ried out in adult cohorts, using the levels of iAs in drink-
ing water at the time of the study as an indicator of iAs 
exposure. However, participants in many of these cohorts 
were likely exposed to iAs for a lifetime, and possibly across 
generations. Yet, no population study to date has system-
atically evaluated association between type 2 diabetes and 
prenatal exposure to iAs. Data from three recent studies sug-
gest the iAs exposure during this developmental window 
may significantly contribute to the diabetogenic phenotypes 
observed in adults. In the first study, gestational iAs expo-
sure was shown to alter CpG methylation of genes in cord 
blood of newborns in Bangladesh; some of these genes were 
associated with the Maturity onset diabetes of the young 
(Mody) pathway (Kile et al. 2014). Similarly, Rojas and 
associates showed that prenatal exposure to iAs-modified 
DNA methylation of 2919 genes in the cord blood of new-
borns in a birth cohort in Mexico (Rojas et al. 2015). Nota-
bly, for 16 of these genes the DNA methylation correlated 
with the transcript levels. Among these genes was imprinted 
gene, KCNQ1, which encodes potassium voltage-gated 
channel sub-family Q member 1, a key regulator of insu-
lin secretion in β-cells. Finally, in the same cohort, mater-
nal exposure to iAs was shown to alter diabetes-associated 
microRNAs in cord blood of newborns (Rager et al. 2014).
When modeling iAs-associated type 2 diabetes in labo-
ratory settings, most studies have focused on iAs exposure 
in adult laboratory animals, mainly mice. Very few stud-
ies have assessed effects of prenatal exposures. In general, 
Table 5  Top pathways in livers of female offspring that were significantly enriched for genes (n = 1407) altered by preconception exposure to iAs
Differentially expressed genes (p < 0.05) were analyzed for pathways enrichment; the significantly enriched pathways were identified using a 
Benjamini–Hochberg adjusted p value < 0.1
Category Pathway Fold enrichment p value Benjamini–Hoch-
berg adjusted p 
value
Gene Ontology Ribosome 4.55 4.07E−21 1.34E−18
KEGG Ribosome 4.66 5.97E−20 1.57E−17
Gene ontology Intracellular ribonucleoprotein complex 3.27 1.84E−17 3.02E−15
Gene ontology Structural constituent of ribosome 3.42 4.95E−16 5.21E−13
Gene ontology Translation 2.36 6.75E−10 2.36E−06
Gene ontology Cytosolic large ribosomal subunit 3.83 1.64E−07 8.29E−06
Gene ontology Mitochondrial inner membrane 3.19 6.91E−20 1.51E−17
Gene ontology Respiratory chain 6.28 2.03E−12 1.67E−10
KEGG Oxidative phosphorylation 3.74 3.56E−12 4.68E−10
Gene ontology Mitochondrial respiratory chain complex I 6.74 1.73E−11 1.26E−09
KEGG Parkinson’s disease 3.40 1.40E−10 1.23E−08
KEGG Huntington’s disease 2.84 3.10E−09 1.63E−07
KEGG Non-alcoholic fatty liver disease (NAFLD) 2.87 1.27E−07 5.55E−06
KEGG Alzheimer’s disease 2.70 2.06E−07 7.73E−06
Gene ontology NADH dehydrogenase (ubiquinone) activity 4.98 4.07E−05 0.007
Gene ontology NADH dehydrogenase activity 8.54 7.20E−05 0.011
Gene ontology Cytosolic small ribosomal subunit 4.78 5.81E−07 2.72E−05
Gene ontology Ribosomal small subunit assembly 7.41 2.59E−06 0.003
Gene ontology Small ribosomal subunit 4.92 3.17E−04 0.009
Gene ontology Peroxisome 3.02 2.03E−06 8.90E−05
KEGG Peroxisome 3.39 3.72E−06 1.22E−04
Gene ontology Peroxisomal membrane 3.29 0.001 0.038
KEGG Valine, leucine and isoleucine degradation 3.07 0.001 0.040
Gene ontology Proteasome complex 3.12 7.69E−04 0.020
Gene ontology Sex chromatin 10.57 0.004 0.087
results of these studies suggest that in utero exposures alone 
or combined with early life exposure to low (ppb) levels of 
iAs in drinking water result in an increased body weight and 
percent fat, and produce adverse metabolic phenotypes char-
acterized by impaired glucose and lipid metabolism in off-
spring, and that these effects are sex dependent (Ditzel et al. 
2016; Rodriguez et al. 2016). Similarly, we have recently 
shown that combined preconception and in utero exposures 
to 100 ppb iAs lead to impaired FBG in adult male, but not 
female C57BL/6 offspring (Huang et al. 2018). In a recent 
study, Fry and associates found that the combined precon-
ception and in utero exposures produced insulin resistance 
in adult male CC004 mice from the Collaborative Cross (Fry 
et al. 2019). In contrast, combined in utero and postnatal 
exposures had no effects on insulin sensitive/resistance in 
this mouse strain. These results suggest that the precon-
ception exposure alone may result in a diabetic phenotype 
in offspring. The goal of the present study was to test this 
hypothesis and to explore a possibility that the effects of the 
preconception exposure may be associated with iAs-induced 
alterations in transcriptomes of the parental germ cell.
We exposed the parent mice to the environmental rel-
evant 200 ppb iAs in drinking water. For comparison, 
chronic exposure to 100 ppb did not produce diabetic phe-
notype in adult C57BL/6 mice in our published studies 
(Douillet et al. 2013). We found no significant differences 
in diabetes indicators between the control and iAs-treated 
mice in the parental group. In clinical studies, diabetes 
during pregnancy, namely gestational diabetes, has been 
a risk factor for development of diabetes in offspring later 
in life (Damm 2009; Damm et al. 2016; Metzger 2007). A 
hyper-insulinogenic and hyper-glycemic fetal environment 
in pregnant women with diabetes, which results in fetal 
epigenetic re-programming of genes involved in energy 
metabolism is thought to drive the diabetic phenotype in 
the offspring (Dabelea 2007; Damm et al. 2016; Metzger 
2007; Nicholas et al. 2016). The fact that in this study, 
dams exposed to iAs did not develop diabetes suggests that 
the altered phenotypes of the offspring from these dams 
are caused by other mechanisms.
We found that the preconception exposure to 200 ppb iAs 
had significant effects on diabetic indicators in C57BL/6 
offspring, but these effects were strictly sex dependent. 
Interestingly, the 23-week-old female offspring from parents 
exposed to iAs prior to mating had higher % fat but lower 
FBG and 15-min blood glucose levels than the female off-
spring from the control parents. This finding seems to con-
tradict a well-established observation that adiposity is a risk 
factor for diabetes in both humans and mice (Farkhondeh 
et al. 2019; Jeon et al. 2015; Navas-Acien et al. 2006). Nota-
bly, the preconception exposure had no significant effects on 
% fat, FBG or 15-min glucose levels in the male offspring. 
However, the higher Δ  glucose(15–0min) and Δ  insulin(15–0min) 
values in the male offspring from iAs-exposed parents are 
suggestive of an impaired glucose tolerance and insulin 
resistance.
Table 6  The pathways that were significantly enriched for genes (n = 95) altered by preconception exposure to iAs in both the parental sperm 
and the liver of male offspring
Genes (p < 0.05) were analyzed for pathways enrichment; the significantly enriched pathways were identified using a Benjamini–Hochberg 
adjusted p value < 0.1
Category Pathway Fold enrichment p value Benjamini–Hoch-
berg adjusted p 
value
Gene Ontology Extracellular matrix 16.16 1.47E−19 2.26E−17
Gene ontology Proteinaceous extracellular matrix 15.04 6.50E−19 5.00E−17
Gene ontology Extracellular region 3.82 8.42E−11 4.32E−09
Gene ontology Extracellular space 3.44 1.90E−07 4.87E−06
Gene ontology Collagen trimer 20.82 1.04E−07 3.20E−06
Gene ontology Platelet-derived growth factor binding 90.86 1.88E−07 3.77E−05
Gene ontology Extracellular matrix structural constituent 31.91 1.10E−06 1.11E−04
KEGG ECM-receptor interaction 16.53 2.79E−06 2.71E−04
KEGG Protein digestion and absorption 16.53 2.79E−06 2.71E−04
KEGG PI3K-Akt signaling pathway 6.51 3.03E−06 1.47E−04
KEGG Focal adhesion 9.03 3.81E−06 1.23E−04
Gene ontology Collagen fibril organization 27.27 3.15E−05 0.010914
Gene ontology Cellular response to amino acid stimulus 10.86 4.24E−05 0.00981
Gene ontology Protein heterotrimerization 44.78 8.88E−05 0.012305
Gene ontology Wound healing 15.84 4.93E−06 0.003428
Gene ontology Cellular response to amino acid stimulus 10.86 4.24E−05 0.00981
To differentiate between the diabetogenic effects of 
fat and those of the preconception iAs exposure, we nor-
malized the blood glucose and insulin indicators in the 
23-week-old offspring and the functional indices derived
from these indicators for % fat. As expected, the nor-
malization did not eliminate the treatment-related dif-
ferences in FBG and 15-min blood glucose levels of the
female offspring. In fact, these differences became even
more statistically significant. In addition, the difference
in Δ  glucose(15–0min) also became statistically significant.
Interestingly, the normalization revealed significant dif-
ferences in FPI and 15-min plasma insulin levels of the
female offspring; both values were lower in females from
parents exposed to iAs than in those from control parents.
Taken together, these results suggest that the female off-
spring from iAs-exposed parents, while having higher %
fat, were able to manage the blood glucose levels during
fasting and after glucose challenge more effectively than
the female offspring from control parents, perhaps due to
greater insulin sensitivity. This conclusion is further sup-
ported by our finding that the % fat-normalized HOMA-IR,
the indicator of insulin resistance, was lower in females
from iAs-exposed parents than in those from control par-
ents. In comparison, in our previous study, a combined
preconception and in utero exposure to 100 ppb iAs had
only a marginal effect on body composition of male or
female offspring and normalization for % fat eliminated
significant differences in FPI and HOMA-IR between iAs-
exposed and control male offspring (Huang et al. 2018). In
that study, no effects of the combined exposure on diabetes
indicators in female offspring were found.
Since body composition of the male offspring was not 
significantly affected by preconception exposure, normal-
izing the diabetes indicators for % fat did not change the 
key observations. The 15-min insulin level remained signifi-
cantly higher in males from iAs-exposed parents (p = 0.003). 
The Δ  insulin(15–0min) value was also higher, but this differ-
ence did not reach statistical significance (p = 0.07). No dif-
ference was found in the normalized HOMA-IR. The differ-
ence in insulinogenic index, a marker of insulin secretion by 
β-cells in response to glucose challenge (Tura et al. 2006), 
which was not significant became statistically significant 
after normalization for % fat. The normalized insulinogenic 
index was significantly higher in the male offspring from 
iAs-exposed parents. These results indicate that the male 
offspring from parents exposed to iAs were able to main-
tain glucose homeostasis during fasting but required greater 
amounts of insulin to support glucose utilization after glu-
cose challenge.
Notably, no significant effects of the preconception expo-
sure were observed in relation to HOMA-B in male and 
female offspring either before or after normalizing for % 
fat. HOMA-B is a marker of β-cell function but is based on 
FBG and FPI values. Thus, it does not reflect mechanisms 
that are activated during glucose challenge.
Exposures to environmental contaminants have been 
shown to alter gene expression profiles in germ cells leading 
to altered phenotypes in offspring (Allegrucci et al. 2005; 
Bollati and Baccarelli 2010; Nilsson et al. 2018). In labora-
tory studies, a daily i.p. injection of iAs (6 mg/kg b.w.) for 
26 days decreased testicular mass and impaired spermato-
genesis in Wistar rats by increasing sperm DNA damage and 
decreasing testicular testosterone, epididymal sperm count, 
and number of germ cells at stage VII (Choudhury et al. 
2011; Sarkar et al. 2003). In mice, a daily oral dose of iAs 
(7.5 mg/kg b.w.) for 35 days has been shown to decrease 
sperm motility, increased sperm morphological abnormality, 
and decreased sperm viability (Ferreira et al. 2012). Adverse 
effects of iAs have also been reported in female germ cells. 
For example, i.p. injection of iAs (16 mg/kg b.w.) for 14 days 
resulted in an increased abnormal spindle and chromosomal 
fragmentation in mature CD-1 oocytes at metaphase II, lead-
ing to meiotic disruption (Navarro et al. 2004). These data 
suggest that iAs exposure impairs structure and function of 
germ cells. However, associations between the iAs-induced 
damage to germ cells and the phenotypic outcomes in off-
spring remain unclear.
The present study is the first to provide evidence of a link 
between iAs-induced differential gene expression in germ 
cells and altered gene transcription profiles in tissues, par-
ticularly liver, of the offspring. Specifically, we found that 
many of the genes and pathways that were altered by iAs 
exposure in paternal sperm and maternal oocytes were also 
altered in the livers of male and female offspring born to the 
iAs-exposed parents. Notably, among these genes and path-
ways were those that are known to be associated with regu-
lation of glucose homeostasis and diabetes. For example, 
PI3K/Akt signaling pathway and pathways are involved in 
maintenance and remodeling of the extracellular matrix. The 
PI3K/Akt signaling is activated by insulin during the post-
prandial stage (White and Kahn 1994). The insulin-depend-
ent activation (phosphorylation) of Akt leads to the translo-
cation of glucose transporter type 4 receptor (GLUT4) from 
the perinuclear compartment to the plasma membrane and 
to stimulation of glucose uptake and utilization (White and 
Kahn 1994). Inhibition of Akt phosphorylation or suppres-
sion of Akt expression is associated with impaired insulin 
signaling and insulin resistance (White and Kahn 1994). 
The extracellular matrix (ECM), which is composed by 
diverse networks of protein and proteoglycans, is involved 
in numerous cellular processes, including signal transduc-
tion and activation of intracellular signaling (e.g., PI3K/Akt 
signaling) (Williams et al. 2015). The pathways involved 
in maintenance and remodeling of the extracellular matrix 
are known to be impaired by diabetes (Law et al. 2012) and 
this impairment is thought to contribute to insulin resistance 
(Williams et al. 2015). Notably, the diabetes-associated path-
ways were dysregulated in the paternal sperm as well as in 
the liver of male offspring, which developed the diabetic 
phenotype. Thus, the iAs-induced differential expression of 
genes in germ cells may be directly responsible for diabetic 
phenotype in male offspring from the iAs-exposed sires.
In summary, our results show that the preconception 
exposure to 200 ppb iAs in drinking water altered diabe-
tes indicators in both male and female offspring that were 
not directly exposed to iAs. Notably, the effects of precon-
ception exposure in the offspring were strictly sex specific. 
While the findings in the male offspring suggest an increase 
requirement for insulin in response to glucose challenge, the 
glucose and insulin indicators in the female offspring are 
consistent with a protective phenotype, despite increased 
adiposity. In addition, this study is the first to link the dia-
betic phenotype of the male offspring to altered gene expres-
sion in the parental germ cells. Molecular mechanisms that 
underlie this link will be investigated in future studies.
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